Clinical trial
Letrozole in Metastatic Breast Cancer in Combination With Chemotherapy
NCT00333047 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00333047 |
|---|---|
| Title | Letrozole in Metastatic Breast Cancer in Combination With Chemotherapy |
| Official title | A Study of Letrozole in the Treatment of Metastatic Breast Cancer in Combination With Chemotherapy |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Metastatic Breast Cancer |
| Intervention type | Drug |
| Interventions | Letrozole |
| Enrollment | 24 |
| Start date | Jul 1, 2002 |
| First posted | Jun 2, 2006 |
| Last update posted | Nov 19, 2009 |
| Countries | Germany |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: